论文部分内容阅读
最近一篇报导注意到1985年前经治疗并多次输血的急性白血病患者中有HTLV-I感染的危险性.因此作者对1978-1985年诊断并治疗的68例急性白血病患者(包括长期存活及死亡者)进行了HTLV-I抗体测定的回顾性筛选.68例中急性非淋巴细胞白血病(ANLL)40例;急性淋巴细胞白血病(ALL)28例.ANLL患者平均输浓缩红细胞37单位(U)(12-61U)和输浓缩血小板81U(50-110U).ALL患者平均输红细胞4U(1-20U),并不定期地输给血小板.血小板从采集在多个塑料袋中的全
A recent report noted the risk of HTLV-I infection in patients with acute leukemia who had been treated and had multiple transfusions before 1985. The authors therefore evaluated the risk of HTLV-I infection in 68 patients with acute leukemia diagnosed and treated between 1978 and 1985, including long-term survival and Death) were retrospectively screened for the determination of HTLV-I antibody in 68 cases of acute non-lymphocytic leukemia (ANLL) in 40 cases of acute lymphoblastic leukemia (ALL) in 28. ANLL patients with an average of 37 units of concentrated erythrocytes (U) (12-61U), and transfused platelet 81U (50-110U). ALL patients lost an average of 4U of erythrocytes (1-20 U) and transplanted irregularly to platelets from platelets collected in multiple plastic bags